Immunobiology of allogeneic hematopoietic stem cell transplantation

Lisbeth A. Welniak, Bruce R. Blazar, William J Murphy

Research output: Contribution to journalArticle

328 Citations (Scopus)

Abstract

Allogeneic hematopoietic stem cell transplantation (HSCT) has evolved into an effective adoptive cellular immunotherapy for the treatment of a number of cancers. The immunobiology of allogeneic HSCT is unique in transplantation in that it involves potential immune recognition and attack between both donor and host. Much of the immunobiology of allogeneic HSCT has been gleaned from preclinical models and correlation with clinical observations. We review our current understanding of some of the issues that affect the success of this therapy, including host-versus-graft (HVG) reactions, graft-versus-host disease (GVHD), graft-versus-tumor (GVT) activity, and restoration of functional immunity to prevent transplant-related opportunistic infections. We also review new strategies to optimize the GVT and improve overall immune function while reducing GVHD and graft rejection.

Original languageEnglish (US)
Pages (from-to)139-170
Number of pages32
JournalAnnual Review of Immunology
Volume25
DOIs
StatePublished - 2007
Externally publishedYes

Fingerprint

Hematopoietic Stem Cell Transplantation
Transplants
Graft vs Host Disease
Adoptive Immunotherapy
Neoplasms
Opportunistic Infections
Graft Rejection
Immunity
Transplantation
Therapeutics

Keywords

  • Graft rejection
  • Graft-versus-host disease
  • Immune reconstitution

ASJC Scopus subject areas

  • Immunology

Cite this

Immunobiology of allogeneic hematopoietic stem cell transplantation. / Welniak, Lisbeth A.; Blazar, Bruce R.; Murphy, William J.

In: Annual Review of Immunology, Vol. 25, 2007, p. 139-170.

Research output: Contribution to journalArticle

Welniak, Lisbeth A. ; Blazar, Bruce R. ; Murphy, William J. / Immunobiology of allogeneic hematopoietic stem cell transplantation. In: Annual Review of Immunology. 2007 ; Vol. 25. pp. 139-170.
@article{f09c5ef5d2334634abad6fe66cb439ef,
title = "Immunobiology of allogeneic hematopoietic stem cell transplantation",
abstract = "Allogeneic hematopoietic stem cell transplantation (HSCT) has evolved into an effective adoptive cellular immunotherapy for the treatment of a number of cancers. The immunobiology of allogeneic HSCT is unique in transplantation in that it involves potential immune recognition and attack between both donor and host. Much of the immunobiology of allogeneic HSCT has been gleaned from preclinical models and correlation with clinical observations. We review our current understanding of some of the issues that affect the success of this therapy, including host-versus-graft (HVG) reactions, graft-versus-host disease (GVHD), graft-versus-tumor (GVT) activity, and restoration of functional immunity to prevent transplant-related opportunistic infections. We also review new strategies to optimize the GVT and improve overall immune function while reducing GVHD and graft rejection.",
keywords = "Graft rejection, Graft-versus-host disease, Immune reconstitution",
author = "Welniak, {Lisbeth A.} and Blazar, {Bruce R.} and Murphy, {William J}",
year = "2007",
doi = "10.1146/annurev.immunol.25.022106.141606",
language = "English (US)",
volume = "25",
pages = "139--170",
journal = "Annual Review of Immunology",
issn = "0732-0582",
publisher = "Annual Reviews Inc.",

}

TY - JOUR

T1 - Immunobiology of allogeneic hematopoietic stem cell transplantation

AU - Welniak, Lisbeth A.

AU - Blazar, Bruce R.

AU - Murphy, William J

PY - 2007

Y1 - 2007

N2 - Allogeneic hematopoietic stem cell transplantation (HSCT) has evolved into an effective adoptive cellular immunotherapy for the treatment of a number of cancers. The immunobiology of allogeneic HSCT is unique in transplantation in that it involves potential immune recognition and attack between both donor and host. Much of the immunobiology of allogeneic HSCT has been gleaned from preclinical models and correlation with clinical observations. We review our current understanding of some of the issues that affect the success of this therapy, including host-versus-graft (HVG) reactions, graft-versus-host disease (GVHD), graft-versus-tumor (GVT) activity, and restoration of functional immunity to prevent transplant-related opportunistic infections. We also review new strategies to optimize the GVT and improve overall immune function while reducing GVHD and graft rejection.

AB - Allogeneic hematopoietic stem cell transplantation (HSCT) has evolved into an effective adoptive cellular immunotherapy for the treatment of a number of cancers. The immunobiology of allogeneic HSCT is unique in transplantation in that it involves potential immune recognition and attack between both donor and host. Much of the immunobiology of allogeneic HSCT has been gleaned from preclinical models and correlation with clinical observations. We review our current understanding of some of the issues that affect the success of this therapy, including host-versus-graft (HVG) reactions, graft-versus-host disease (GVHD), graft-versus-tumor (GVT) activity, and restoration of functional immunity to prevent transplant-related opportunistic infections. We also review new strategies to optimize the GVT and improve overall immune function while reducing GVHD and graft rejection.

KW - Graft rejection

KW - Graft-versus-host disease

KW - Immune reconstitution

UR - http://www.scopus.com/inward/record.url?scp=34247867901&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247867901&partnerID=8YFLogxK

U2 - 10.1146/annurev.immunol.25.022106.141606

DO - 10.1146/annurev.immunol.25.022106.141606

M3 - Article

C2 - 17129175

AN - SCOPUS:34247867901

VL - 25

SP - 139

EP - 170

JO - Annual Review of Immunology

JF - Annual Review of Immunology

SN - 0732-0582

ER -